Author

M. Shokrollahi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Seyfoori· 1 shared J. Lum· 1 shared M. Akbari· 1 shared M. Amereh· 1 shared P. Walter· 1 shared S. Lane· 1 shared S. Shojaei· 1 shared T. Zhao· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Seyfoori

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic Vulnerabilities of Temozolomide-Resistant Glioblastoma Cells: Implications for Targeted Therapies and Overcoming Chemoresistance

M. Amereh, A. Seyfoori, S. Shojaei, S. Lane, T. Zhao, M. Shokrollahi, J. Lum, P. Walter, M. Akbari

The paper identifies metabolic vulnerabilities in TMZ-resistant glioblastoma cells, showing that iron reduction enhances the efficacy of TMZ through mechanisms involving Hif1, autophagy, and ROS.

bioRxiv · Mar 1, 2024 · PreprintCancer Biology